Official registry condition

Stage IV Prostate Cancer peptide trials

6 selected ClinicalTrials.gov records carrying the official condition label Stage IV Prostate Cancer. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

6 selected records.

Connected peptides

3 profiles.

Registry update years

2017–2021 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases3

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses1

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 109 selected PubMed records and 27 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Stage IV Prostate Cancer unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT01468532

PeptideScanner retained ClinicalTrials.gov record NCT01468532 at 2026-11-15T22:05:38.400Z. Its registry update date was 2021-03-25, and PeptideScanner's reviewed identity mapping was pasireotide.

PeptideScanner change date
November 15, 2026
Cited source date
March 25, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01731912

PeptideScanner retained ClinicalTrials.gov record NCT01731912 at 2026-11-15T21:52:09.579Z. Its registry update date was 2019-01-18, and PeptideScanner's reviewed identity mapping was degarelix.

PeptideScanner change date
November 15, 2026
Cited source date
January 18, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02489357

PeptideScanner retained ClinicalTrials.gov record NCT02489357 at 2026-11-15T21:52:09.579Z. Its registry update date was 2021-11-12, and PeptideScanner's reviewed identity mapping was degarelix.

PeptideScanner change date
November 15, 2026
Cited source date
November 12, 2021
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →